Convalescent plasma for COVID-19 in hospitalised patients: an open-label, randomised clinical trial.
Leo SekineBeatriz ArnsBruna R FabroMurillo M CipolattRafael R G MachadoEdison L DurigonEdino ParoloJosé Augusto S PellegriniMarina V VianaPatrícia SchwarzThiago C LisboaJosé Miguel S DoraJúlia P PortichAlessandra A PazLucia SillaAlmeri M BalsanFelipe da-Silva SchirmerJuliana P M FranzLuciana M da-SilveiraRaquel C BreunigViviana PetersenMonalisa SosnoskiNanci F MesquitaFabiana Caroline Z VolpatoDaniel SganzerlaMaicon FalavignaRegis G RosaAlexandre Prehn Zavasckinull nullPublished in: The European respiratory journal (2021)
CP+SOC did not result in a higher proportion of clinical improvement on at day 28 in hospitalised patients with COVID-19 compared to SOC alone.